The C-Suite at The Open video interview series highlights the unique perspectives of listed companies on Toronto Stock Exchange and TSX Venture Exchange. Videos provide insight into how company executives think in the current business environment. To see the latest C-Suite at The Open videos visit https://www.tmxmoney.com/en/csuite.html .
Khiron Life Sciences Corp. is the dominant integrated medical cannabis company in Latin America . It has core operations in Latin America , along with activity in North America and Europe , and is licensed in Colombia for the cultivation, production, domestic distribution, and international export of both tetrahydrocannabinol (THC) and cannabidiol (CBD) medical cannabis. The company addresses priority medical conditions such as chronic pain, epilepsy, depression and anxiety in the Latin American market. Its segments include Medical cannabis products, Health services, and Wellbeing products. Its operations in Latin America derives majority of the revenue. For more information visit: http://www.khiron.ca/
About TMX Group (TSX: X)
TMX Group's key subsidiaries operate cash and derivative markets and clearinghouses for multiple asset classes including equities and fixed income. Toronto Stock Exchange , TSX Venture Exchange , TSX Alpha Exchange , The Canadian Depository for Securities , Montréal Exchange , Canadian Derivatives Clearing Corporation , Trayport and other TMX Group companies provide listing markets, trading markets, clearing facilities, depository services, technology solutions, data products and other services to the global financial community. TMX Group is headquartered in Toronto and operates offices across North America (Montréal, Calgary , Vancouver and New York ), as well as in key international markets including London , Beijing and Singapore . For more information about TMX Group, visit our website at www.tmx.com . Follow TMX Group on Twitter: @TMXGroup .
SOURCE TMX Group Limited
View original content to download multimedia: http://www.newswire.ca/en/releases/archive/November2020/25/c6552.html